Cargando…
Encouraging probiotics for the prevention and treatment of immune-related adverse events in novel immunotherapies against malignant glioma
Among the malignant tumors in the central nervous system (CNS), glioma is the most challenging tumor to the public society, which accounts for the majority of intracranial malignant tumors with impaired brain function. In general, conventional therapies are still unable to provide an effective cure....
Autores principales: | Yoshikawa, Sayuri, Taniguchi, Kurumi, Sawamura, Haruka, Ikeda, Yuka, Tsuji, Ai, Matsuda, Satoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Exploration
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834274/ https://www.ncbi.nlm.nih.gov/pubmed/36654824 http://dx.doi.org/10.37349/etat.2022.00114 |
Ejemplares similares
-
Encouraging Tactics with Genetically Modified Probiotics to Improve Immunity for the Prevention of Immune-Related Diseases including Cardio-Metabolic Disorders
por: Asai, Tomoko, et al.
Publicado: (2022) -
Presumed Roles of APRO Family Proteins in Cancer Invasiveness
por: Ikeda, Yuka, et al.
Publicado: (2022) -
A New Concept of Associations between Gut Microbiota, Immunity and Central Nervous System for the Innovative Treatment of Neurodegenerative Disorders
por: Yoshikawa, Sayuri, et al.
Publicado: (2022) -
Potential tactics with certain gut microbiota for the treatment of unresectable hepatocellular carcinoma
por: Yoshikawa, Sayuri, et al.
Publicado: (2023) -
Potential tactics with vitamin D and certain phytochemicals for enhancing the effectiveness of immune-checkpoint blockade therapies
por: Tsuji, Ai, et al.
Publicado: (2023)